Description
CINRYZE
First action · last action
2015-04-24 · 2015-04-24
Transactions
1
First transaction's obligation
$102,583
Base + all options value (sum of deltas)
$102,583
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5260B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-04-24+$102,583= $102,583
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-04-24 | +$102,583 | $102,583 | CINRYZE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MGHZQ16KEN33)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA26117F0002 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $588,793 | FY2017 |
| VA24216F1927 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $61,550 | FY2016 |
| VA25917E0759 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,194 | FY2016 |
| VA797P16A0020 | NAC PHARMACEUTICALS 36P797 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA24816F0837 | 248-NETWORK CONTRACT OFFICE 8 · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $68,497 | FY2016 |
| VA52816F0220 | 242-NETWORK CONTRACT OFFICE 02 · 6505 · DRUGS AND BIOLOGICALS | $184,649 | FY2016 |
Other recipients under 6505 from 437-FARGO VA MEDICAL CENTER (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26316J0415 | SANOFI VACCINES US INC. | 437-FARGO VA MEDICAL CENTER | $42,503 | FY2016 |
| VA26316J0414 | SEQIRUS USA INC | 437-FARGO VA MEDICAL CENTER | $62,900 | FY2016 |
| VA26316J0399 | SEQIRUS USA INC | 437-FARGO VA MEDICAL CENTER | $52,207 | FY2016 |
| VA26316J0411 | SANOFI VACCINES US INC. | 437-FARGO VA MEDICAL CENTER | $141,675 | FY2016 |
| VA26316J0389 | CSL BEHRING L.L.C. | 437-FARGO VA MEDICAL CENTER | $14,281 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26315J0455_3600_V797P5260B_3600 · retrieved 2026-09-26.